VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Mabwell's Denosumab Injection (9MW0321) Receives NMPA Approval for Expanded Indications
Mabwell's Denosumab Injection (9MW0321) Receives NMPA Approval for Expanded Indications
May 20, 2026 16:19 CST Updated 17:03
Share:
Mabwell
Innovative Biopharmaceutical Company
